Center for Psychiatry and Behavioral Medicine

Las Vegas, Nevada 89128

0 studies enrolling now · 20 studies all time

What they study most

ADHD, Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorders, Attention-Deficit/Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type, Autistic Disorder, Behavioral Symptoms

Studies at this site

• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) — Completed
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD). — Completed
• A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder — Stopped early
• Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD — Completed
• Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD — Completed
• Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant — Completed
• PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD — Completed
• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) — Completed
• Software Treatment for Actively Reducing Severity of ADHD — Completed
• PK/PD Pediatric ADHD Classroom Study — Completed
• PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD — Completed
• Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Study — Completed
• Software Treatment for Actively Reducing Severity of ADHD - Follow Up — Completed
• NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity ) — Completed
• An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• Study of Fluoxetine in Autism — Completed
• Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) — Completed